Evidence map›Paper›PMID 31640990›Full record

ArticleBMJ open2019

Using telemedicine to support care for people with type 2 diabetes mellitus: a qualitative analysis of patients' perspectives.

Jun Yang Lee, Carina Ka Yee Chan, Siew Siang Chua, Thomas Paraidathathu, Kenneth Kwing-Chin Lee, Christina San San Tan, Nazrila Nasir, Shaun Wen Huey Lee

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 3 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 3 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. The influence of telemedicine in primary healthcare on diabetes mellitus control and treatment adherence in Riyadh region.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Jun Yang LeeSchool of Pharmacy, Monash University - Malaysia Campus, Bandar Sunway, Malaysia.
Carina Ka Yee ChanLa Trobe University College of Science Health and Engineering, Bundoora, Victoria, Australia.
Siew Siang ChuaSchool of Pharmacy, Taylor's University - Lakeside Campus, Subang Jaya, Malaysia.
Thomas ParaidathathuSchool of Pharmacy, Taylor's University - Lakeside Campus, Subang Jaya, Malaysia.
Kenneth Kwing-Chin LeeSchool of Pharmacy, Monash University - Malaysia Campus, Bandar Sunway, Malaysia.
Christina San San TanHELP International Corporation Bhd, Kuala Lumpur, Malaysia.
Nazrila NasirKementerian Kesihatan Malaysia, Putrajaya, Malaysia.
Shaun Wen Huey LeeSchool of Pharmacy, Monash University - Malaysia Campus, Bandar Sunway, Malaysia shaun.lee@monash.edu.ORCID 0000-0001-7361-6576
Monash University Malaysia · MYTaylor's University · MYHELP International Corporation (Malaysia) · MYLa Trobe University · AUMinistry of Health · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTelemedicine has been promoted as an economical and effective way to enhance patient care, but its acceptance among patients in low-income and middle-income countries is poorly understood. This study is aimed to explore the experiences and perspectives of people with type 2 diabetes mellitus that used telemedicine to manage their condition.

designIn-depth and focus group interviews were conducted with participants who have engaged in telemedicine. Questions included were participants' perception on the programme being used, satisfaction as well as engagement with the telemedicine programme. All interviews and focus groups were audio-recorded and transcribed verbatim. Data were analysed using a thematic approach. PARTICIPANTS AND

settingPeople with type 2 diabetes (n=48) who participated in a randomised controlled study which examined the use of telemedicine for diabetes management were recruited from 11 primary care clinics located within the Klang Valley.

resultsTwelve focus groups and two in-depth interviews were conducted. Four themes emerged from the analysis: (1) generational difference; (2) independence and convenience, (3) sharing of health data and privacy and (4) concerns and challenges. The main obstacles found in patients using the telemedicine systems were related to internet connectivity and difficulties experienced with system interface. Cost was also another significant concern raised by participants. Participants in this study were primarily positive about the benefits of telemedicine, including its ability to provide real-time data and disease monitoring and the reduction in clinic visits.

conclusionDespite the potential benefits of telemedicine in the long-term care of diabetes, there are several perceived barriers that may limit the effectiveness of this technology. As such, collaboration between educators, healthcare providers, telecommunication service providers and patients are required to stimulate the adoption and the use of telemedicine.NCT0246680.

Indexed as

Self CareTelemedicineAge FactorsAttitude to ComputersComputer SecurityConfidentialityCosts and Cost AnalysisDiabetes Mellitus, Type 2FemaleFocus GroupsHumansInformation DisseminationInternet AccessInterviews as TopicMalaysiaMalebarriersdiabetespatient perspectivequalitativetelemedicine

Identifiers

PMID31640990
PMCPMC6830613
OpenAlexW2981325486

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.